Rate of Comorbidities Not Related to HIV Infection or AIDS among HIV‐Infected Patients, by CD4 Cell Count and HAART Use Status
Open Access
- 15 October 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (8), 1102-1104
- https://doi.org/10.1086/592115
Abstract
The rate of comorbidities not related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) among HIV-infected patients may be higher than expected. We assessed the incidence of comorbidities not related to HIV infection or AIDS by CD4 cell count and highly active antiretroviral therapy (HAART) use status in an HIV clinical practice. A total of 2824 patients contributed 9172 person-years of longitudinal data during the period 1997–2006. Among patients with a CD4 cell count 3, receipt of HAART was associated with a significantly decreased incidence of comorbidities not related to HIV infection or AIDS.Keywords
This publication has 10 references indexed in Scilit:
- U.S. Disparities in Health: Descriptions, Causes, and MechanismsAnnual Review of Public Health, 2008
- Racial and Ethnic Disparities in the VA Health Care System: A Systematic ReviewJournal of General Internal Medicine, 2008
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- CD4+ Count–Guided Interruption of Antiretroviral TreatmentNew England Journal of Medicine, 2006
- Mortality in the Highly Active Antiretroviral Therapy EraJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Hospitalizations for Metabolic Conditions, Opportunistic Infections, and Injection Drug Use Among HIV PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Estimating the proportion of patients infected with HIV who will die of comorbid diseasesAmerican Journal Of Medicine, 2005
- Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcoholJournal of Hepatology, 2005
- Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapyCancer, 2004
- Understanding the Clinical and Economic Outcomes of HIV Therapy: The Johns Hopkins HIV Clinical Practice CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998